For: | Ranieri G, Ammendola M, Marech I, Laterza A, Abbate I, Oakley C, Vacca A, Sacco R, Gadaleta CD. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients. World J Gastroenterol 2015; 21(19): 6018-6025 [PMID: PMC4438038 DOI: 10.3748/wjg.v21.i19.6018] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i19/6018.htm |
Number | Citing Articles |
1 |
Bernhard Scheiner, Gregor Ulbrich, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Fredrik Waneck, Michael Trauner, Claus Kölblinger, Arnulf Ferlitsch, Wolfgang Sieghart, Markus Peck-Radosavljevic, Matthias Pinter. Short‐ and long‐term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. United European Gastroenterology Journal 2019; 7(6): 850 doi: 10.1177/2050640619840199
|
2 |
Carmelo Laface, Palma Fedele, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Pasquale Molinari, Michele Ammendola, Marco Lioce, Girolamo Ranieri. Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. Cancers 2022; 14(16): 4028 doi: 10.3390/cancers14164028
|
3 |
Zhitao Li, Jia Ding, Xiuyun Zhao, Gaofu Qi. Combination Therapy of Hepatocellular Carcinoma by Dna Shuffling-Based Vegf Vaccine and Doxorubicin. Immunotherapy 2018; 10(11): 951 doi: 10.2217/imt-2017-0194
|
4 |
Zhi-Huan Lin, Jun-Rong Jiang, Xiao-Kun Ma, Jie Chen, He-Ping Li, Xing Li, Xiang-Yuan Wu, Ming-Sheng Huang, Qu Lin. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma. Clinical and Experimental Medicine 2021; 21(1): 109 doi: 10.1007/s10238-020-00667-8
|
5 |
Michele Ammendola, Cosmo Damiano Gadaleta, Adam Enver Frampton, Tullio Piardi, Riccardo Memeo, Valeria Zuccalà, Maria Luposella, Rosa Patruno, Nicola Zizzo, Pietro Gadaleta, Patrick Pessaux, Rosario Sacco, Giuseppe Sammarco, Girolamo Ranieri. The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients. Oncotarget 2017; 8(41): 70463 doi: 10.18632/oncotarget.19716
|
6 |
D. A. Kaprin. Intra-arterial regional chemotherapy for pancreatic cancer (review). Translational Medicine 2023; 9(6): 16 doi: 10.18705/2311-44952022-9-6-16-25
|
7 |
Zonghong Han, Zhongming He, Caoye Wang, Qi Wang. The effect of apatinib in the treatment of sorafenib resistant metastatic hepatocellular carcinoma. Medicine 2018; 97(49): e13388 doi: 10.1097/MD.0000000000013388
|
8 |
Rosa Patruno, Giuseppe Passantino, Carmelo Laface, Antonella Tinelli, Alfredo Zito, Roberta Ruggieri, Francesco Luposella, Pietro Gadaleta, Mariarita Laforgia, Luca Lacitignola, Michele Ammendola, Girolamo Ranieri, Nicola Zizzo. Microvascular Density, Endothelial Area, and Ki-67 Proliferative Index Correlate Each Other in Cat Post-Injection Fibrosarcoma. Cells 2020; 10(1): 31 doi: 10.3390/cells10010031
|
9 |
Alicia González, Carolina Alonso-González, Alicia González-González, Javier Menéndez-Menéndez, Samuel Cos, Carlos Martínez-Campa. Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments. Cancers 2021; 13(13): 3263 doi: 10.3390/cancers13133263
|
10 |
Giovanni Paolino, Paola Corsetti, Elisa Moliterni, Serena Corsetti, Dario Didona, Marcello Albanesi, Carlo Mattozzi, Paolo Lido, Stefano Calvieri. Mast cells and cancer. Giornale Italiano di Dermatologia e Venereologia 2019; 154(6) doi: 10.23736/S0392-0488.17.05818-7
|
11 |
Kaizhen Wang, Kuojun Zhang, Xiangyu Zhang, Dong Chen, Sheng Jiang. Recent Insights of Metformin on Hepatocellular Carcinoma (HCC). Mini-Reviews in Medicinal Chemistry 2023; 23(11): 1154 doi: 10.2174/1389557522666220623150717
|
12 |
Susanne Smolka, Julius Chapiro, Wilfred Manzano, John Treilhard, Eric Reiner, Yanhong Deng, Yan Zhao, Bernd Hamm, James S. Duncan, Bernhard Gebauer, MingDe Lin, Jean-François Geschwind. The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma. Clinical Imaging 2017; 46: 1 doi: 10.1016/j.clinimag.2017.05.007
|
13 |
Hui‐Hui Zhang, Ying Zhang, Yan‐Na Cheng, Fu‐Lian Gong, Zhan‐Qi Cao, Lu‐Gang Yu, Xiu‐Li Guo. Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo. Molecular Carcinogenesis 2018; 57(1): 44 doi: 10.1002/mc.22718
|
14 |
Chen Zhou, Qi Yao, Hongsen Zhang, Xiaopeng Guo, Jiacheng Liu, Qin Shi, Songjiang Huang, Bin Xiong. Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59746-1
|
15 |
Ilaria Marech, Michele Ammendola, Christian Leporini, Rosa Patruno, Maria Luposella, Nicola Zizzo, Giuseppe Passantino, Rosario Sacco, Ammad Ahmad Farooqi, Valeria Zuccalà, Silvana Leo, Rosalba Dentamaro, Mariangela Porcelli, Pietro Gadaleta, Giovambattista De Sarro, Cosmo Damiano Gadaleta, Girolamo Ranieri. C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients. Oncotarget 2018; 9(8): 7918 doi: 10.18632/oncotarget.23722
|
16 |
Xinxiang Yang, Wai-Ho Oscar Yeung, Kel Vin Tan, Tak-Pan Kevin Ng, Li Pang, Jie Zhou, Jinyang Li, Changxian Li, Xiangcheng Li, Chung Mau Lo, Weiyuan John Kao, Kwan Man. Development of cisplatin-loaded hydrogels for trans-portal vein chemoembolization in an orthotopic liver cancer mouse model. Drug Delivery 2021; 28(1): 520 doi: 10.1080/10717544.2021.1895908
|
17 |
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Ruoyu Guan, Boyong Shen, Chenghong Peng. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(7): 1286 doi: 10.1111/jgh.13727
|
18 |
Zhimei Cheng, Huanrong Qin, Wei Cao, Huizhou He, Shuling Zhang, Yushi Yang, Zhenmin Wang, Xun Zou, Lizhou Wang, Xueqing Huang, Shi Zhou, Shuai Zhang. Intravoxel incoherent motion imaging used to assess tumor microvascular changes after transarterial chemoembolization in a rabbit VX2 liver tumor model. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1114406
|
19 |
Heba Sedrak, Noaman El-Garem, Mervat Naguib, Heba El-Zawahry, Mohamed Esmat, Lila Rashed. Vascular endothelial growth factor before and after locoregional treatment and its relation to treatment response in hepatocelluar carcinoma patients. Asian Pacific Journal of Tropical Biomedicine 2015; 5(12): 1005 doi: 10.1016/j.apjtb.2015.09.006
|
20 |
Irina Chekmaryova, Dmitry Kalinin, Andrey Kostin, Igor Buchwalow, Markus Tiemann, Daniel Elieh‐Ali‐Komi, Dmitrii Atiakshin. Ultrastructural features of tumor‐associated mast cells in parasympathetic paragangliomas (chemodectomas) of the neck. Microscopy Research and Technique 2024; 87(6): 1373 doi: 10.1002/jemt.24523
|
21 |
Katrin Fuchs, Rafael Duran, Alban Denys, Pierre E. Bize, Gerrit Borchard, Olivier Jordan. Drug-eluting embolic microspheres for local drug delivery – State of the art. Journal of Controlled Release 2017; 262: 127 doi: 10.1016/j.jconrel.2017.07.016
|
22 |
Ge Zhang, Shuai Gong, Lina Pang, Lixia Hou, Wei He. Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659217
|
23 |
Yan Fu, Chu Hui Zeng, Chao An, Yue Liu, Ji Hoon Shin, Xiao Li. How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles. Cancers 2023; 15(4): 1324 doi: 10.3390/cancers15041324
|
24 |
Jan Zavadil, Jaroslav Juracek, Barbora Cechova, Tomas Rohan, Jakub Husty, Ondrej Slaby, Martina Litschmannova, Michal Uher, S. Nahum Goldberg, Tomas Andrasina. Tumor Suppressor miR-34a: Potential Biomarker of TACE Response in HCC. CardioVascular and Interventional Radiology 2025; 48(1): 26 doi: 10.1007/s00270-024-03908-5
|
25 |
Wenxian Cui, Yuanguo Li, Keqing Xu, Guijin Chen, Xiaoqun Lu, Qiuqin Duan, Zhirong Kang. RETRACTED: miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA. Biochemical and Biophysical Research Communications 2016; 479(4): 901 doi: 10.1016/j.bbrc.2016.09.076
|
26 |
Girolamo Ranieri, Carmelo Laface. Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated Treatments. Cancers 2020; 12(10): 2737 doi: 10.3390/cancers12102737
|
27 |
Daniel A. Butcher, Kelli J. Brandis, Haolu Wang, Liam Spannenburg, Kim R. Bridle, Darrell HG. Crawford, Xiaowen Liang. Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology 2022; 48(3): 621 doi: 10.1016/j.ejso.2021.09.017
|
28 |
Carmelo Laface, Girolamo Ranieri, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Michele Ammendola, Marigia Laterza, Gerardo Cazzato, Riccardo Memeo, Giovanni Mastrandrea, Marco Lioce, Palma Fedele. Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma. Cancers 2023; 15(3): 654 doi: 10.3390/cancers15030654
|
29 |
Carmelo Laface, Mariarita Laforgia, Pasquale Molinari, Ippazio Ugenti, Cosmo Damiano Gadaleta, Camillo Porta, Girolamo Ranieri. Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art. Cancers 2021; 13(12): 3091 doi: 10.3390/cancers13123091
|
30 |
KAI WU, LIUCHENG YANG, ZONGHAI HUANG, HAIJUN ZHAO, JIANJUN WANG, SHUAI XU. A double suicide gene system driven by vascular endothelial growth factor promoter selectively kills human hepatocellular carcinoma cells. Oncology Letters 2016; 11(5): 3152 doi: 10.3892/ol.2016.4360
|
31 |
De-Dong Cao, Hui-Lin Xu, Liang Liu, Yong-Fa Zheng, Si-Fa Gao, Xi-Ming Xu, Wei Ge. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(27): 44976 doi: 10.18632/oncotarget.16689
|
32 |
Khaled Farid, Hatem Elalfy, Salwa M. Abo El-khair, Hoda Elgamal, Tarek Besheer, Ali Elmokadem, Walaa Shabana, Sally Abed, Mohamed Elegezy, Ahmed Abd El-khalek, Ahmed El-Morsy, Amr Negm, Ayman Z. Elsamanoudy, Basem El deek, Talal Amer, Mahmoud El-Bendary. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients. Expert Review of Gastroenterology & Hepatology 2020; 14(12): 1203 doi: 10.1080/17474124.2020.1823215
|
33 |
Stepan M. Esagian, Christos D. Kakos, Emmanouil Giorgakis, Lyle Burdine, J. Camilo Barreto, Michail N. Mavros. Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers 2021; 13(12): 2984 doi: 10.3390/cancers13122984
|
34 |
Xiaoyan Ding, Wei Sun, Jinglong Chen, Wei Li, Yanjun Shen, Xiaodi Guo, Ying Teng, Xiaomin Liu, Shasha Sun, Jianying Wei, Wendong Li, Hui Chen, Bozhi Liu. Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.578633
|
35 |
Yuxin Duan, Hua Zhang, Tao Tan, Wentao Ye, Kunli Yin, Yanxi Yu, Meiqing Kang, Jian Yang, Rui Liao. The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy. BioScience Trends 2023; 17(6): 427 doi: 10.5582/bst.2023.01275
|
36 |
Carmelo Laface, Mariarita Laforgia, Pasquale Molinari, Caterina Foti, Francesca Ambrogio, Cosmo Damiano Gadaleta, Girolamo Ranieri. Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review. Cancers 2022; 14(2): 450 doi: 10.3390/cancers14020450
|
37 |
Xiang Li, Guangwei He, Feng Su, Zhaoxing Chu, Leiming Xu, Yazhong Zhang, Jianping Zhou, Yang Ding. Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma. Asian Journal of Pharmaceutical Sciences 2020; 15(6): 739 doi: 10.1016/j.ajps.2020.01.001
|
38 |
Miltiadis Krokidis, Danae Fakitsa, Katerina Malagari, Theodoros Karampelas, Demosthenes Fokas, Constantin Tamvakopoulos, Achilles Chatziioannou. Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2024; 47(5): 661 doi: 10.1007/s00270-024-03714-z
|